Sensitization of rhTRAIL-resistant Triple-negative Breast Carcinoma Through Silibinin Co-Treatment
Jasmine M. Manouchehri(The Ohio State University), Michael Kalafatis(Cleveland State University)
Cited by 7
Related Papers
The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer
|Breast Cancer Research|2024|7
Augmentation of extracellular ATP synergizes with chemotherapy in triple negative breast cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2022|0
The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0
Sulfatase 2 Inhibition Sensitizes Triple-Negative Breast Cancer Cells to Chemotherapy Through Augmentation of Extracellular ATP
|bioRxiv (Cold Spring Harbor Laboratory)|2023|0